Ireland
--:--IST
Starting soon Not applicable

High Dimensional Computing Gesture Recognition

NCT07155460 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-01-15
Last updated
2026-01-20

Condition(s) studied

Healthy Volunteers

Investigational drug(s) / intervention(s)

HDC-GCog

HDC-GCog: Surface electromyography records

Study summary

The primary objective of this study is the Improvement of gesture recognition and classification accuracy through the use of the HDC algorithm compared to other classification methods (KNN, RF, SGD, NC). The recognition rate will be expressed by the sensitivity and specificity of gesture recognition. The model will be trained on a portion of the dataset and tested on the remaining part to avoid any bias.

The secondaries objectives are the :

* Improvement of gesture recognition accuracy with our HDC algorithm compared to other standard models.
* Calculation of gesture recognition rates depending on the number of electrodes used and their position.
* Subject's assessment of device comfort rated above 6 on a 10-level visual analog scale.
* Subject's assessment of ease of performing the gesture rated above 6 on a 10-level visual analog scale.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Healthy, right-handed volunteer subject, * Male or female, * Age between 18 and 65 years inclusive, * BMI \< 30 kg/m², * Minimum forearm circumference less than 15 cm, * Subjects agree to shaving or trimming of the right forearm. * Agreement to the study non-opposition form, * Subject affiliated with a social security scheme, * Registered in the national database of individuals who participate in biomedical research Exclusion Criteria: * Subject with a known motor problem in the right forearm and hand, * Known allergy or intolerance to one of the electrode components, * Presence of a lesion in the measurement area, * Subject with an active medical implant (e.g. pacemaker, cochlear implant, etc.), * Subject wearing a contraceptive implant in the measurement area. * Female subject aware of pregnancy at the time of measurement, * Subject refusing to shave or trim the area or whose body hair precludes shaving or trimming the area, * Presence of a pathology likely to alter the EMG. * Persons referred to in Articles L1121-5 to L1121-8 of the Public Health Code (corresponds to all protected persons: pregnant women, women in labour, breastfeeding mothers, persons deprived of their liberty by judicial or administrative decision, persons receiving psychiatric care under Articles L. 3212-1 and L. 3213-1 who do not fall under the provisions of Article L. 1121-8, persons admitted to a health or social establishment for purposes other than research, minors, persons subject to a legal protection measure or unable to express their consent).

Primary outcome measure(s)

  • Gesture recognition rate using a device composed of 32 high-frequency surface EMG electrodes — 3 hours
    Calculation of gesture recognition rate expressed in percentage of gesture recognition

Trial sites (1)

FacilityCityRegionStatus
Clinatec Cea/Chuga Grenoble France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07155460 on ClinicalTrials.gov ↗ ← All trials in France